SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $52,078,000 | +43.4% | 266,129 | +24.6% | 0.03% | +14.8% |
Q2 2020 | $36,307,000 | +141.0% | 213,670 | +63.7% | 0.03% | +80.0% |
Q1 2020 | $15,063,000 | +0.6% | 130,560 | -0.4% | 0.02% | -28.6% |
Q4 2019 | $14,979,000 | +1810.6% | 131,097 | +1327.3% | 0.02% | +2000.0% |
Q3 2019 | $784,000 | +47.9% | 9,185 | +19.9% | 0.00% | 0.0% |
Q2 2019 | $530,000 | -68.5% | 7,663 | -66.6% | 0.00% | -66.7% |
Q1 2019 | $1,680,000 | -37.0% | 22,959 | -33.6% | 0.00% | -40.0% |
Q3 2018 | $2,668,000 | +1207.8% | 34,596 | +786.4% | 0.01% | +400.0% |
Q1 2018 | $204,000 | -56.6% | 3,903 | -55.6% | 0.00% | 0.0% |
Q4 2017 | $470,000 | -20.2% | 8,785 | -18.8% | 0.00% | -50.0% |
Q3 2017 | $589,000 | -21.3% | 10,821 | -25.1% | 0.00% | -33.3% |
Q2 2017 | $748,000 | -25.1% | 14,455 | -23.6% | 0.00% | -25.0% |
Q4 2016 | $998,000 | +105.8% | 18,909 | +110.4% | 0.00% | +100.0% |
Q3 2016 | $485,000 | -81.4% | 8,986 | -84.5% | 0.00% | -87.5% |
Q4 2015 | $2,605,000 | +263.8% | 58,055 | +292.3% | 0.02% | +220.0% |
Q2 2015 | $716,000 | – | 14,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |